Drug patch tests in the investigation of cutaneous adverse drug reactions;Patch-tests medicamenteux dans l'exploration des toxidermies

Annales de Dermatologie et de Venereologie

Volumn 136, Issue 8-9, 2009, Pages 635-644

  Barbaud, A ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Cutaneous adverse drug reaction; Drug patch tests

Indexed keywords

ABACAVIR; ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; AZATHIOPRINE; BETA LACTAM ANTIBIOTIC; BLEOMYCIN; CAPTOPRIL; CARBAMAZEPINE; CARBIMAZOLE; CEFADROXIL; CELECOXIB; CIPROFLOXACIN; CLINDAMYCIN; CLOBAZAM; CORTICOSTEROID; DILTIAZEM; DIPYRONE; ESOMEPRAZOLE; FLUINDIONE; HEPARIN DERIVATIVE; METHOXSALEN; METRONIDAZOLE; MORPHINE; NIMESULIDE; PSEUDOEPHEDRINE; RANITIDINE; SPIRONOLACTONE; TETRAZEPAM; TUBERCULOSTATIC AGENT; UNINDEXED DRUG;

ACUTE GENERALIZED EXANTHEMATOUS PUSTULOSIS; DRESS SYNDROME; DRUG ERUPTION; DRUG HYPERSENSITIVITY; FIXED DRUG ERUPTION; HUMAN; PATCH TEST; PHOTOPATCH TEST; PHOTOSENSITIVITY; REVIEW; SKIN ALLERGY; STEVENS JOHNSON SYNDROME; TECHNIQUE; TOXIC EPIDERMAL NECROLYSIS;

EID: 69049090687     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annder.2009.06.021     Document Type: Article

References (91)

1. A. Barbaud Drug patch testing in systemic cutaneous drug allergy Toxicology 209 2005 209 216
2. A. Barbaud, S. Reichert-Penetrat, P. Trechot, M.A. Jacquin-Petit, A. Ehlinger, and V. Noirez, et al. The use of skin testing in the investigation of cutaneous adverse drug reactions Br J Dermatol 139 1998 49 58
3. A. Barbaud, M. Gonçalo, D. Bruynzeel, and A. Bircher Guidelines for performing skin tests with drugs in the investigation of cutaneous adverse drug reactions Contact Dermatitis 45 2001 321 328
4. A. Barbaud Drug skin tests and systemic drug reactions: an update Expert Rev Dermatol 2 2007 481 495
5. M. Kleinhans, L. Linzbach, S. Zedlitz, R. Kaufmann, and W.H. Boehncke Positive patch test reactions to celecoxib may be due to irritation and do not correlate with the results of oral provocation Contact Dermatitis 47 2002 100 102
6. A. Barbaud, A.C. Bursztejn, J.L. Schmutz, and Ph. Trechot Patch tests with desloratadine at 10% induce false-positive results: test at 1% J Eur Acad Dermatol Venereol 22 2008 1504 1505
7. A. Barbaud, P. Trechot, S. Reichert-Penetrat, N. Commun, and J.L. Schmutz Relevance of skin tests with drugs in investigating cutaneous adverse drug reactions Contact Dermatitis 45 2001 265 268
8. V. Conilleau, A. Dompmartin, M. Michel, L. Verneuil, and D. Leroy Photoscratch testing in systemic drug-induced photosensitivity Photodermatol Photoimmunol Photomed 16 2000 62 66
9. K. Alanko, S. Stubb, and S. Reitamo Topical provocation of fixed drug eruption Br J Dermatol 116 1987 561 567
10. C.E. Klein, A. Trautmann, D. Zillikens, and E.B. Brocker Patch testing in an unusual case of toxic epidermal necrolysis Contact Dermatitis 33 1995 448 449
11. A. Barbaud, P. Trechot, S. Reichert-Penetrat, F. Granel, and J.L. Schmutz Drug patch testing: the usefulness in testing on the most previously affected site in a systemic cutaneous adverse drug reaction to tetrazepam Contact Dermatitis 44 2001 259 260
12. A. Mahboob, T.S. Haroon, Z. Iqbal, F. Iqbal, M.A. Saleemi, and A. Munir Fixed drug eruption: topical provocation and subsequent phenomena J Coll Physicians Surg Pak 16 2006 747 750
13. V.N. Sehgal, and G. Srivastava Fixed drug eruption (FDE): changing scenario of incriminating drugs Int J Dermatol 45 2006 897 908
14. R. Gupta Drugs causing fixed drug eruptions: confirmed by provocation tests Indian J Dermatol Venereol Leprol 69 2003 120 121
15. K. Lammintausta, and O. Kortekangas-Savolainen The usefulness of skin tests to prove drug hypersensitivity Br J Dermatol 152 2005 968 974
16. D.P. Bruynzeel, and W.G. Van Ketel Skin tests in the diagnosis of maculopapular drug eruptions Sem Dermatol 6 1987 119 124
17. A. Padial, C. Antunez, N. Blanca-Lopez, T.D. Fernandez, J.A. Cornejo-Garcia, and C. Mayorga, et al. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test Clin Exp Allergy 38 2008 822 828
18. P. Wolkenstein, O. Chosidow, M.L. Flechet, O. Robbiola, M. Paul, and L. Dume, et al. Patch testing in severe cutaneous adverse drug reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis Contact Dermatitis 35 1996 234 236
19. G.E. Elston, G.A. Johnston, N.J. Mortimer, and K.E. Harman Acute generalized exanthematous pustulosis associated with azathioprine hypersensitivity Clin Exp Dermatol 32 2007 52 53
20. M.J. Harries, S.J. McIntyre, and T.P. Kingston Co-amoxiclav-induced acute generalized exanthematous pustulosis confirmed by patch testing Contact Dermatitis 55 2006 372
21. A. Altaykan, G. Boztepe, G. Erkin, O. Ozkaya, and E. Ozden Acute generalized exanthematous pustulosis induced by bleomycin and confirmed by patch testing J Dermatolog Treat 15 2004 231 234
22. A. Grange-Prunier, B. Roth, I. Kleinclaus, J.P. Fagot, and J.C. Guillaume Pustulose exanthématique aigue généralisée due au carbimazole (Néomercazole) : premier cas et valeur des patch tests Ann Dermatol Venereol 133 2006 708 710
23. P. Hausermann, K. Scherer, M. Weber, and A.J. Bircher Ciprofloxacin-induced acute generalized exanthematous pustulosis mimicking bullous drug eruption confirmed by a positive patch test Dermatology 211 2005 277 280
24. M. Valois, E.J. Phillips, N.H. Shear, and S.R. Knowles Clindamycin-associated acute generalized exanthematous pustulosis Contact Dermatitis 48 2003 169
25. U. Buettiker, M. Keller, W.J. Pichler, L.R. Braathen, and N. Yawalkar Oral prednisolone induced acute generalized exanthematous pustulosis due to corticosteroids of group A confirmed by epicutaneous testing and lymphocyte transformation tests Dermatology 213 2006 40 43
26. M. Girardi, K.O. Duncan, R.E. Tigelaar, S. Imaeda, K.L. Watsky, and J.M. McNiff Cross-comparison of patch test and lymphocyte proliferation responses in patients with a history of acute generalized exanthematous pustulosis Am J Dermatopathol 27 2005 343 346
27. M.A. Gonzalo-Garijo, R. Pérez-Calderón, D. De Argila, and I. Rodríguez-Nevado Metamizole-induced acute generalized exanthematous pustulosis Contact Dermatitis 49 2003 47 48
28. C. Morant, T. Devis, I. Alcaraz, L. Lefevre, J. Caron, and P. Modiano Pustulose exanthématique aigue généralisée au méthoxalène (Méladinine) avec positivité des tests épicutanés Ann Dermatol Venereol 129 2002 234 235
29. S.H. Kardaun, and J.G. de Monchy Acute generalized exanthematous pustulosis caused by morphine, confirmed by positive patch test and lymphocyte transformation test J Am Acad Dermatol 55 2006 S21 S23
30. M. Teixeira, E. Silva, and M. Selores Acute generalized exanthematous pustulosis induced by nimesulide Dermatol Online J 12 2006 20
31. E. Mayo-Pampín, A. Flórez, C. Feal, A. Conde, M.T. Abalde, and C. De la Torre Acute generalized exanthematous pustulosis due to pseudoephedrine with positive patch test Acta Derm Venereol 86 2006 542 543
32. M.A. Padial, J. Alvarez-Ferreira, B. Tapia, R. Blanco, C. Mañas, and M. Blanca Acute generalized exanthematous pustulosis associated with pseudoephedrine Br J Dermatol 150 2004 139 142
33. M.B. Martínez, J.F. Salvador, G.V. Aguilera, I.B. Mas, and J.C. Ramírez Acute generalized exanthematous pustulosis induced by ranitidine hydrochloride Arch Dermatol 139 2003 1181 1183
34. E. Thomas, T. Bellón, P. Barranco, A. Padial, B. Tapia, and E. Morel Acute generalized exanthematous pustulosis due to tetrazepam J Invest Allergol Clin Immunol 18 2008 119 122
35. J.H. Lee, H.K. Park, J. Heo, T.O. Kim, G.H. Kim, and D.H. Kang, et al. Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs J Korean Med Sci 23 2008 521 525
36. H. Bel Hadj Ali, M. Youssef, A. Chaabane, M. Amri, N.A. Boughattas, and J.E. Zili Carbamazepine-induced DRESS and HHV6 primary infection: the importance of skin tests Epilepsia 49 2008 1630 1633
37. P. Gaig, P. García-Ortega, M. Baltasar, and J. Bartra Drug neosensitization during anticonvulsant hypersensitivity syndrome J Invest Allergol Clin Immunol 16 2006 321 326
38. A. Antunes, A. Davril, P. Trechot, M. Grandidier, F. Truchetet, and J.F. Cuny Syndrome d'hypersensibilité à la minocycline Ann Dermatol Venereol 126 1999 518 521
39. Suswardana, M. Hernanto, B.A. Yudani, S.R. Pudjiati, and N. Indrastuti DRESS syndrome from cefadroxil confirmed by positive patch test Allergy 62 2007 1216 1217
40. S. Caboni, N. Gunera-Saad, S. Ktiouet-Abassi, F. Berard, and J.F. Nicolas Esomeprazole-induced DRESS syndrome. Studies of cross-reactivity among proton-pump inhibitor drugs Allergy 62 2007 1342 1343
41. E. Frouin, B. Roth, A. Grange, F. Grange, M.C. Tortel, and J.C. Guillaume Syndrome d'hypersensibilité à la fluindione (Pré viscan®). Positivité des tests épicutanés Ann Dermatol Venereol 132 2005 1000 1002
42. P.D. Ghislain, A.D. Bodarwe, O. Vanderdonckt, D. Tennstedt, L. Marot, and J.M. Lachapelle Drug-induced eosinophilia and multisystemic failure with positive patch test reaction to spironolactone: DRESS syndrome Acta Derm Venereol 84 2004 65 68
43. N. Shear, B. Milpied, D.P. Bruynzeel, and E. Phillips A review of drug patchtesting and implications for HIV clinicians AIDS 22 2008 1 9
44. Milpied-Homsi B, Lefebvre A, Aquilina C, Carbonnel E, Adamski H, Machet L, et al. Cutaneous patchtesting and genetic markers in the diagnostic of antiretroviral drug reactions in HIV patients. In: 10th European AIDS Conference. Dublin 2005 (Abstract PE9.9/2).
45. A. Romano, M. Di Fonso, D. Pocobelli, L. Giannarini, A. Venuti, and A. Garcovich Two cases of toxic epidermal necrolysis caused by delayed hypersensitivity to beta-lactam antibiotics J Invest Allergol Clin Immunol 3 1993 53 55
46. H. Tagami, K. Tatsuta, K. Iwatski, and M. Yamada Delayed hypersensitivity in ampicillin-induced toxic epidermal necrolysis Arch Dermatol 119 1983 910 913
47. P.S. Friedmann, I. Strickland, M. Pirmohamed, and B.K. Park Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine Arch Dermatol 130 1994 598 604
48. J.J. Nagge, S.R. Knowles, D.N. Juurlink, and N.H. Shear Pseudoephedrine-induced toxic epidermal necrolysis Arch Dermatol 141 2005 907 908
49. C. Goossens, U. Sass, and M. Song Baboon syndrome Dermatology 194 1997 421 422
50. A. Barbaud, P. Trechot, F. Granel, Lonchamp Ph, G. Faure, and J.L. Schmutz, et al. A baboon syndrome induced by intravenous human immunoglobulins: report of a case and immunological analysis Dermatology 199 1999 258 260
51. A.W. Arnold, P. Hausermann, S. Bach, and A.J. Bircher Recurrent flexural exanthema (SDRIFE or baboon syndrome) after administration of two different iodinated radio contrast media Dermatology 214 2007 89 93
52. R. Gallo, and A. Parodi Baboon syndrome from 5-aminosalicylic acid Contact Dermatitis 46 2002 110
53. T.S. Sánchez, J. Sánchez-Pérez, M. Aragüés, and A. García-Díaz Flare-up reaction of pseudoephedrine baboon syndrome after positive patch test Contact Dermatitis 42 2000 312 313
54. C. Cholez, P. Trechot, J.L. Schmutz, G. Faure, M.C. Bene, and A. Barbaud Maculopapular rash induced by diltiazem: allergological investigations in four patients and cross-reactions between calcium channel blockers Allergy 58 2003 1207 1209
55. C. Pirker, A. Misic, T. Brinkmeier, and P.J. Frosch Tetrazepam drug sensitivity - usefulness of the patch test Contact Dermatitis 47 2002 135 138
56. K. Lammintausta, L. Mäkela, and K. Kalimo Rapid systemic valaciclovir reaction subsequent to aciclovir contact allergy Contact Dermatitis 45 2001 181
57. C. Vernassiere, A. Barbaud, P.H. Trechot, F. Weber-Muller, and J.L. Schmutz Systemic acyclovir reaction subsequent to acyclovir contact allergy: which systemic antiviral drug should then be used? Contact Dermatitis 49 2003 155 157
58. M.J. Trujillo, M. de Barrio, A. Rodriguez, M. Moreno-Zazo, I. Sanchez, and R. Pelta Piroxicam-induced photodermatitis. Cross-reactivity among oxicams. A case report Allergol Immunopathol (Madr) 29 2001 133 136
59. M. Gonçalo, and A. Figueiredo Cross-reactions among oxicams in cutaneous adverse drug reactions Contact Dermatitis 46 2002 s31
60. R. Barranco, A. Rodriguez, M. de Barrio, M.J. Trujillo, C. de Frutos, and V. Matheu, et al. Sympathomimetic drug allergy: cross-reactivity study by patch test Am J Clin Dermatol 5 2004 351 355
61. R.J. Ludwig, M. Schindewolf, J. Utikal, E. Lindhoff-Last, and W.H. Boehncke Management of cutaneous type IV hypersensitivity reactions induced by heparin Thromb Haemost 96 2006 611 617
62. C. Vernassiere, P. Trechot, J.L. Schmutz, and A. Barbaud Results and negative value of skin tests in investigating delayed reactions to radio-contrast media Contact Dermatitis 50 2004 359 366
63. J. Waton, P. Tréchot, C. Loss-Ayav, J.L. Schmutz, and A. Barbaud Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions Br J Dermatol 160 2009 786 794
64. J. Mashiah, and S. Brenner A systemic reaction to patch testing for evaluation of acute generalized exanthematous pustulosis Arch Dermatol 139 2003 1181 1183
65. G. Ulrich, J.L. Schmutz, Trechot Ph, N. Commun, and A. Barbaud Sensitization to petrolatum: an unusual cause of false positive drug patch tests Allergy 59 2004 1006 1009
66. T. Sakakibara, M. Hata, K. Numano, Y. Kawase, S. Yamanishi Tkawana, and N. Tsuboi Fixed-drug eruption caused by allylisopropylacetylurea Contact Dermatitis 44 2001 189 190
67. A. Romano, M. Di Fonso, F. Pietrantonio, D. Pocobelli, L. Giannarini, and A. Del Bono, et al. Repeated patch testing in delayed hypersensitivity to beta-lactam antibiotics Contact Dermatitis 28 1993 190
68. A. Romano, M. Viola, C. Mondino, R. Pettinato, M. di Fonso, and G. Papa, et al. Diagnosing nonimmediate reactions to penicillins by in vivo tests Int Arch Allergy Immunol 129 2002 169 174
69. P. Gaig, M.M. San Miguel-Moncin, J. Bartra, A. Bonet, and P. Garcia-Ortega Usefulness of patch tests for diagnosing selective allergy to captopril J Invest Allergol Clin Immunol 11 2001 204 206
70. A. Kawada, Y. Aragane, A. Maeda, M. Asai, H. Shiraishi, and T. Tezuka Drug eruption induced by cefcapene pivoxil hydrochloride Contact Dermatitis 44 2001 197
71. S. Verbeiren, C. Morant, H. Charlanne, K. Ajebbar, J. Caron, and P. Modiano Toxidermie due au celecoxib avec tests épicutanés positifs Ann Dermatol Venereol 129 2002 203 205
72. V.L. Brown, and D.I. Orton Cutaneous adverse drug reaction to oral chlorphenamine detected with patch testing Contact Dermatitis 52 2005 49 50
73. A. Rodriguez-Morales, A. Alonso Llamazares, R. Palacios Benito, and C. Martinez Cocera Fixed drug eruption from quinolones with a positive lesional patch test to ciprofloxacin Contact Dermatitis 44 2001 255
74. L. Machet, L. Vaillant, V. Dardaine, and G. Lorette Patch testing with clobazam: relapse of generalized drug eruption Contact Dermatitis 26 1992 347 348
75. J.L. Estrada, M.J. Alvarez Puebla, J.J. Ortiz de Urbina, B. Matilla, M.A. Rodriguez Priet, and F. Gozalo Generalized eczema due to codeine Contact Dermatitis 44 2001 185
76. E. Ozkaya-Bayazit, H. Bayazit, and G. Ozarmagan Topical provocation in 27 cases of cotrimoxazole-induced fixed drug eruption Contact Dermatitis 41 1999 185 189
77. R.H. Felix, and J.S. Comaish The value of the patch tests and other skin tests in drug eruptions Lancet 1 1974 1017 1019
78. M.J. Jonker, and D. Bruynzeel Anaphylactic reaction elicited by patch testing with diclofenac Contact Dermatitis 49 2003 114 115
79. K. Scherer, D.A. Tsakiris, and A.J. Bircher Hypersensitivity reactions to anticoagulant drugs Curr Pharm Des 14 2008 2863 2873
80. S. Rebello, P. Sanchez, J.M. Vega, E. Sedano, M.E. Sanchis, T. Asensio, and A. Callejo Hypersensitivity syndrome from isoniazid with positive patch test Contact Dermatitis 45 2001 306
81. D. Quinones Estevez, and C. Fernandez Schmitz Exanthema to metamizole Allergy 56 2001 262 263
82. K. Sasaki, T. Yamamoto, M. Kishi, H. Yokozeki, and K. Nishioka Acute exanthematous pustular drug eruption induced by mexiletine Eur J Dermatol 11 2001 469 471
83. D. Malheiro, S. Cadinha, J. Rodrigues, M. Vaz, and M.G. Castel-Branco Nimesulide-induced fixed drug eruption Allergol Immunopathol (Madr) 33 2005 285 287
84. R. Barranco, P. Tornero, M. De Barrio, C. De Frutos, A. Rodriguez, and M. Rubio Type IV hypersensitivity to oral nystatin Contact Dermatitis 45 2001 60
85. A. Barbaud, P. Trechot, F. Weber-Muller, G. Ulrich, N. Commun, and J.L. Schmutz Drug skin tests in cutaneous adverse drug reactions to pristinamycin: 29 cases with a study of cross-reactions between synergistins Contact Dermatitis 50 2004 22 26
86. K. Brockow, C. Christiansen, G. Kanny, O. Clement, A. Barbaud, and A. Bircher, et al. Management of hypersensitivity reactions to iodinated contrast media Allergy 60 2005 150 158
87. R.M. Gueant-Rodriguez, A. Romano, A. Barbaud, K. Brockow, and J.L. Gueant Hypersensitivity reactions to iodinated contrast media Curr Pharm Des 12 2006 3359 3372
88. T.S. Sanchez, J. Sanchez-Perez, M. Aragues, and A. Garcia-Diaz Flare-up reaction of pseudoephedrine baboon syndrome after positive patch test Contact Dermatitis 42 2000 312 313
89. R.M. Strauss, S.T. Green, and D.J. Gawkrodger Rifampicin allergy confirmed by an intradermal test, but with a negative patch test Contact Dermatitis 45 2001 108
90. N. Bernedo, I. Gonzalez, G. Gastaminza, M. Audicana, E. Fernandez, and D. Munoz Positive patch test in vancomycin allergy Contact Dermatitis 45 2001 43
91. D.A. Wong, and S. Freeman Cutaneous allergic reaction to intramuscular vitamin K1 Australas J Dermatol 40 1999 147 152